Literature DB >> 9713577

Effects of zinc gluconate on nephrotoxicity and glutathione metabolism disorder induced by cis-platin in mice.

Y Huang1, S Zhou, L Qui, J Wu, C Xu.   

Abstract

To examine the effects of zinc gluconate (ZG) on the nephrotoxicity of cis-platin (CDDP), changes in renal function and glutathione metabolism were investigated in mice. Fifty mice were randomly divided into five equal groups: controls, CDDP group and three ZG plus CDDP groups; the dose of ZG was 100 mg, 140 mg and 180 mg/kg respectively. Mice were sacrificed after 48 hours of CDDP (9 mg/kg) treatment; the levels of serum creatinine (Cr) and blood urea nitrogen (BUN) were measured, the glutathione (GSH) and malondialdehyde (MDA) content and the activities of glutathione peroxidase (GHS-PX) and catalase (CAT) in whole blood and renal tissue were assayed. Compared to the control group, there were significant increases in Cr, BUN and MDA, and decreases in the activities of GSH-PX in the CDDP group in whole blood and renal tissue. Preadministration of ZG at the doses of 140 mg/kg and 180 mg/kg significantly increased the concentration of GSH in whole blood, and decreased the levels of Cr and BUN, and the MDA content in whole blood and renal tissue, compared with the CDDP group. We conclude that preadministration of ZG might improve renal function and glutathione metabolism and reduce the nephrotoxicity of cis-platin.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9713577     DOI: 10.1515/dmdi.1997.14.1.41

Source DB:  PubMed          Journal:  Drug Metabol Drug Interact        ISSN: 0792-5077


  3 in total

1.  The anti-tumour agent, cisplatin, and its clinically ineffective isomer, transplatin, produce unique gene expression profiles in human cells.

Authors:  Anne M Galea; Vincent Murray
Journal:  Cancer Inform       Date:  2008-06-10

2.  Cisplatin-induced regulation of signal transduction pathways and transcription factors in p53-mutated subclone variants of hepatoma cells: Potential application for therapeutic targeting.

Authors:  Jinn-Rung Kuo; Hung-Sheng Shang; Chun-Te Ho; Kun-Goung Lai; Tsan-Zon Liu; Yin-Ju Chen; Jeng-Fong Chiou
Journal:  Oncol Lett       Date:  2016-09-23       Impact factor: 2.967

Review 3.  Cisplatin-Induced Nephrotoxicity; Protective Supplements and Gender Differences

Authors:  Mehdi Nematbakhsh; Zahra Pezeshki; Fatemeh Eshraghi Jazi; Bahar Mazaheri; Maryam Moeini; Tahereh Safari; Fariba Azarkish; Fatemeh Moslemi; Maryam Maleki; Alireza Rezaei; Shadan Saberi; Aghdas Dehghani; Maryam Malek; Azam Mansouri; Marzieh Ghasemi; Farzaneh Zeinali; Zohreh Zamani; Mitra Navidi; Sima Jilanchi; Soheyla Shirdavani; Farzaneh Ashrafi
Journal:  Asian Pac J Cancer Prev       Date:  2017-02-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.